NRC Health
NRC
$18.62
-$0.31-1.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 138.64M | 137.39M | 139.10M | 140.31M | 141.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 138.64M | 137.39M | 139.10M | 140.31M | 141.30M |
| Cost of Revenue | 52.96M | 52.37M | 52.79M | 55.69M | 56.13M |
| Gross Profit | 85.68M | 85.02M | 86.32M | 84.63M | 85.16M |
| SG&A Expenses | 51.21M | 48.15M | 51.59M | 50.31M | 43.80M |
| Depreciation & Amortization | 8.25M | 7.62M | 7.00M | 6.35M | 6.12M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 112.42M | 108.15M | 111.37M | 112.34M | 106.05M |
| Operating Income | 26.22M | 29.25M | 27.73M | 27.97M | 35.25M |
| Income Before Tax | 14.50M | 17.85M | 23.45M | 24.48M | 32.22M |
| Income Tax Expenses | 5.47M | 6.25M | 7.09M | 6.55M | 8.01M |
| Earnings from Continuing Operations | 9.04 | 11.60 | 16.36 | 17.93 | 24.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.04M | 11.60M | 16.36M | 17.93M | 24.21M |
| EBIT | 26.22M | 29.25M | 27.73M | 27.97M | 35.25M |
| EBITDA | 34.47M | 36.87M | 34.73M | 34.32M | 41.37M |
| EPS Basic | 0.39 | 0.50 | 0.70 | 0.76 | 1.03 |
| Normalized Basic EPS | 0.60 | 0.69 | 0.65 | 0.66 | 0.86 |
| EPS Diluted | 0.38 | 0.49 | 0.70 | 0.76 | 1.03 |
| Normalized Diluted EPS | 0.60 | 0.69 | 0.65 | 0.66 | 0.86 |
| Average Basic Shares Outstanding | 88.37M | 89.55M | 91.11M | 92.71M | 93.92M |
| Average Diluted Shares Outstanding | 88.51M | 89.57M | 91.13M | 92.74M | 94.00M |
| Dividend Per Share | 0.56 | 0.52 | 0.48 | 0.48 | 0.48 |
| Payout Ratio | 130.95% | 94.63% | 67.82% | 62.39% | 46.75% |